⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 9, 2024Neurology

Patterns of Steroid Use and Outcomes in US Patients with Generalized Myasthenia Gravis (gMG) Receiving C5 Inhibitor Therapy (C5IT) (P10-11.011)

Justin Lee Karen Yee Michael Blackowicz Ema Rodrigues Ashley Yegin Guido Sabatella

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Assess disease outcomes and changes in corticosteroid use in patients with gMG receiving C5ITs.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Lee et al. (2024) studied this question.

synapsesocial.com/papers/68e6fdb8b6db64358767801f https://doi.org/10.1212/wnl.0000000000204654

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Comorbidity Burden and Steroid Use in Generalized Myasthenia Gravis: A Retrospective Analysis of Medicare Fee-for-service Claims (P4-11.015)2024 · 1 citations
2Real-world Treatment Patterns, Discontinuation, and Treatment Switches in Patients With Generalized Myasthenia Gravis (gMG): A Retrospective Claims Analysis (P4-9.003)Cohort Study · 2026
3Targeted biologics in muscle strength restoration and corticosteroid sparing for patients post-myasthenic crisisOriginal Research · 2026
4Exploring side effects of corticosteroids in myasthenia gravis: Unveiling alternatives for safer treatment2024 · 1 citations
5Real-world treatment patterns and disease burden in generalized myasthenia gravis patients receiving non-steroidal immunosuppressants within the Brazilian public health system: a claims database studyCohort Study · 2026